Bioluminescent RNA Lanterns for In Vivo Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for visualizing RNA dynamics in live animals are limited by the need for invasive procedures, excitation light, and phototoxicity, which hinder the tracking of RNA lifecycles in real-time due to low signal-to-noise ratios and tissue damage.
Innovation Solution
The development of bioluminescent RNA lanterns using split fragments of NanoLuc fused to MS2 and PP7 bacteriophage coat proteins, which assemble into a functional light-emitting enzyme upon binding to specific RNA aptamers, enabling non-invasive, real-time visualization of RNA without excitation light and minimizing phototoxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional fluorescent probes are used for RNA visualization, then RNA can be tracked in cells, but excitation light is required which causes autofluorescence and phototoxicity, precluding sensitive detection and real-time tracking in live animals
Solution Approach 1:
The patent replaces the optical excitation system (fluorescence) with a biochemical system (bioluminescence). Instead of using external light sources that cause autofluorescence and phototoxicity, the invention uses luciferase enzymes that catalyze chemical reactions to produce light internally, eliminating the need for excitation light and thereby resolving the contradiction between measurement precision and harmful factors
Solution Approach 2:
The RNA molecules are equipped with self-contained bioluminescent tags (luciferase enzymes or aptamers that bind luminescent proteins) that generate their own light signal without requiring external excitation. This self-service approach allows the RNA to be visualized autonomously in live animals without subjecting the tissue to harmful external light sources
2Reliability
If invasive procedures or tissue excision are performed to deliver fluorescent dyes, then RNA imaging can be achieved, but the procedures are invasive and limit real-time tracking
Solution Approach 1:
The patent replaces mechanical delivery methods (invasive surgery, tissue excision, dye injection) with a genetic approach. The bioluminescent tags are delivered via viral vectors or plasmids that transduce or transfect cells, allowing non-invasive genetic modification. Once expressed, the cells continuously produce the luminescent signal, enabling reliable long-term imaging without repeated invasive procedures
Solution Approach 2:
The invention performs preliminary genetic modification of the cells to express bioluminescent RNA tags before imaging. This advance preparation ensures that the cells are inherently luminescent and can be imaged repeatedly over time without requiring further invasive intervention, thus resolving the contradiction between imaging reliability and operational ease
3Object-affected harmful factors
If short imaging times are used to avoid light-induced damage, then phototoxicity is minimized, but the ability to trace RNA lifecycles in real time is lost
Solution Approach 1:
The patent substitutes the harmful external light source with an internal biochemical light-generating system. The luciferase-luciferin reaction produces light without requiring external illumination, eliminating the time constraint imposed by light-induced damage. This allows continuous, long-duration imaging to capture complete RNA lifecycles without accumulating phototoxic effects
Solution Approach 2:
The bioluminescent system enables continuous imaging over extended periods because it does not rely on external light sources that cause tissue damage. The enzymatic light production can be sustained as long as luciferin is supplied, allowing uninterrupted observation of RNA dynamics from transcription through degradation, thus resolving the contradiction between minimizing harm and maintaining imaging continuity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides superior signal-to-noise ratios and allows for serial imaging of RNA dynamics in vivo, enabling the observation of RNA production kinetics and localization without disrupting cellular processes.
Implementation Method 1
bioluminescence can provide superior signal-to-noise ratios in vivo for visualization of low-copy transcripts
Implementation Method 2
photon production from luciferase enzymes and luciferin small molecules
Implementation Method 3
MCP and PCP bind distinct RNA aptamers (MS2 and PP7, respectively) that can be appended to transcripts of interest
Data Source
AI summary
A complete understanding of RNA biology requires methods for tracking transcripts in vivo. Common strategies rely on fluorogenic probes that are limited in sensitivity, dynamic range, and depth of interrogation, owing to their need for excitation light and tissue autofluorescence. To overcome these challenges, a bioluminescent platform for serial imaging of RNAs is described herein. Small RNA tags were engineered to recruit light-emitting luciferase fragments (termed RNA lanterns) upon transcription. Robust photon production was observed for RNA targets both in cells and in live animals. Importantly, only a single copy of the tag was necessary for sensitive detection, in sharp contrast to fluorescent platforms requiring multiple repeats. Overall, this work provides a foundational platform for visualizing RNA dynamics from the micro to the macro scale.